Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Consun Pharmaceutical Group Limited (C1P.F)

Compare
0.9100
-0.0600
(-6.19%)
At close: April 4 at 8:05:45 AM GMT+2
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,590,115
2,590,115
2,339,650
2,044,660
1,752,830
Cost of Revenue
668,437
668,437
576,738
517,324
431,159
Gross Profit
1,921,678
1,921,678
1,762,912
1,527,336
1,321,671
Operating Expense
1,099,048
1,099,048
1,043,455
875,024
767,882
Operating Income
822,630
822,630
719,457
652,312
553,789
Net Non Operating Interest Income Expense
47,653
47,653
41,481
26,343
6,487
Pretax Income
863,703
863,703
746,393
695,861
583,736
Tax Provision
77,149
77,149
62,696
108,744
101,993
Net Income Common Stockholders
784,534
784,534
682,907
590,172
498,788
Diluted NI Available to Com Stockholders
784,534
784,534
682,907
590,172
498,788
Basic EPS
0.99
0.99
0.86
0.74
0.61
Diluted EPS
0.98
0.98
0.86
0.73
0.61
Basic Average Shares
790,908
790,908
790,627
801,581
817,264
Diluted Average Shares
799,168
799,168
791,997
804,702
817,264
Total Operating Income as Reported
884,967
884,967
757,326
708,766
605,137
Total Expenses
1,767,485
1,767,485
1,620,193
1,392,348
1,199,041
Net Income from Continuing & Discontinued Operation
784,534
784,534
682,907
590,172
498,788
Normalized Income
785,304.7060
785,304.7060
684,022.6880
591,851.5600
498,989.3000
Interest Income
68,917
68,917
52,414
39,248
27,888
Interest Expense
21,264
21,264
10,933
12,905
21,401
Net Interest Income
47,653
47,653
41,481
26,343
6,487
EBIT
884,967
884,967
757,326
708,766
605,137
EBITDA
963,056
963,056
833,681
781,755
676,932
Reconciled Cost of Revenue
668,437
668,437
576,738
517,324
431,159
Reconciled Depreciation
78,089
78,089
76,355
72,989
71,795
Net Income from Continuing Operation Net Minority Interest
784,534
784,534
682,907
590,172
498,788
Total Unusual Items Excluding Goodwill
-846
-846
-1,218
-1,990
-244
Total Unusual Items
-846
-846
-1,218
-1,990
-244
Normalized EBITDA
963,902
963,902
834,899
783,745
677,176
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
-75.2940
-75.2940
-102.3120
-310.4400
-42.7000
12/31/2020 - 1/3/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELTP Elite Pharmaceuticals, Inc.
0.3200
+0.09%
 
PTPI Petros Pharmaceuticals, Inc.
0.0670
-2.19%
 
SBFM Sunshine Biopharma, Inc.
1.5700
-14.67%
 
TLRY Tilray Brands, Inc.
0.5922
-4.16%